BioCentury
ARTICLE | Company News

LTS Lohamnn Therapie-Systeme AG, Novartis, BWK GmbH, dievini Hopp BioTech drug delivery news

August 18, 2014 7:00 AM UTC

LTS said that dievini Hopp, which is one of LTS’s three main shareholders and has 24% stake, will acquire LTS by purchasing a 43% stake in LTS held by Novartis and a 24% stake held by BWK. Additionall...